Lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide
C78H84Cl4LiN23O13S — CID 161110727
Data last refreshed: (MolForge compound catalog, from PubChem)
About Lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide
Lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide (PubChem CID 161110727) has the molecular formula C78H84Cl4LiN23O13S and a molecular weight of 1732.50 g/mol. Its IUPAC name is lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide.
Molecular Properties
| Compound Name | Lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide |
|---|---|
| PubChem CID | 161110727 |
| Molecular Formula | C78H84Cl4LiN23O13S |
| Molecular Weight | 1732.50 g/mol |
| Exact Mass | 1729.53 |
| IUPAC Name | lithium;4-chloro-3-methyl-N-(4-methylphenyl)-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide;4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylic acid;ethyl 4-chloro-3-methyl-1-[(6-methylpyridazin-3-yl)methyl]pyrazolo[3,4-b]pyridine-5-carboxylate;ethyl 4-chloro-3-methyl-2H-pyrazolo[3,4-b]pyridine-5-carboxylate;(6-methylpyridazin-3-yl)methanol;(6-methylpyridazin-3-yl)methyl methanesulfonate;oxolane;hydroxide |
| SMILES | C1CCOC1.CCOC(=O)c1cnc2c(c(C)nn2Cc2ccc(C)nn2)c1Cl.CCOC(=O)c1cnc2n[nH]c(C)c2c1Cl.Cc1ccc(CO)nn1.Cc1ccc(COS(C)(=O)=O)nn1.Cc1ccc(Cn2nc(C)c3c(Cl)c(C(=O)O)cnc32)nn1.Cc1ccc(NC(=O)c2cnc3c(c(C)nn3Cc3ccc(C)nn3)c2Cl)cc1.[Li+].[OH-] |
| InChI | InChI=1S/C21H19ClN6O.C16H16ClN5O2.C14H12ClN5O2.C10H10ClN3O2.C7H10N2O3S.C6H8N2O.C4H8O.Li.H2O/c1-12-4-7-15(8-5-12)24-21(29)17-10-23-20-18(19(17)22)14(3)27-28(20)11-16-9-6-13(2)25-26-16;1-4-24-16(23)12-7-18-15-13(14(12)17)10(3)21-22(15)8-11-6-5-9(2)19-20-11;1-7-3-4-9(18-17-7)6-20-13-11(8(2)19-20)12(15)10(5-16-13)14(21)22;1-3-16-10(15)6-4-12-9-7(8(6)11)5(2)13-14-9;1-6-3-4-7(9-8-6)5-12-13(2,10)11;1-5-2-3-6(4-9)8-7-5;1-2-4-5-3-1;;/h4-10H,11H2,1-3H3,(H,24,29);5-7H,4,8H2,1-3H3;3-5H,6H2,1-2H3,(H,21,22);4H,3H2,1-2H3,(H,12,13,14);3-4H,5H2,1-2H3;2-3,9H,4H2,1H3;1-4H2;;1H2/q;;;;;;;+1;/p-1 |
| InChIKey | UJQPRNMFIDFOLC-UHFFFAOYSA-M |
| XLogP | 9.31 |
| TPSA | 484.43 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 120 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1732.50 |
| LogP ≤ 5 | 9.31 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161110727 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.